Home
>
National Drug Code (NDC)
>
Idarubicin Hydrochloride
Idarubicin Hydrochloride - 0703-4156-11 - (idarubicin hydrochloride)
Drug Information of Idarubicin Hydrochloride
| Product NDC: | 0703-4156 |
| Proprietary Name: | Idarubicin Hydrochloride |
| Non Proprietary Name: | idarubicin hydrochloride |
| Active Ingredient(s): | 1 mg/mL & nbsp; idarubicin hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Idarubicin Hydrochloride
| Product NDC: | 0703-4156 |
| Labeler Name: | Teva Parenteral Medicines, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065036 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20021001 |
Package Information of Idarubicin Hydrochloride
| Package NDC: | 0703-4156-11 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4156-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
NDC Information of Idarubicin Hydrochloride
| NDC Code | 0703-4156-11 |
| Proprietary Name | Idarubicin Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 CARTON (0703-4156-11) > 20 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 0703-4156 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | idarubicin hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20021001 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Parenteral Medicines, Inc |
| Substance Name | IDARUBICIN HYDROCHLORIDE |
| Strength Number | 1 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
